Osteocalcin, cortisol levels, and bone mineral density in prepubertal children with asthma treated with long-term fluticasone propionate

Hormone Research in Paediatrics

Volumn 77, Issue 6, 2012, Pages 351-357

  Ozkaya, Emin ^a,c   Nursoy, Mustafa A ^a   Uzuner, Selcuk ^c   Erenberk, Ufuk ^c   Akr, Erkan ^b  

^a Divisions of Pediatric Allergy   (Turkey)

^b Divisions of Pediatric Pulmonology   (Turkey)

^c BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Asthma; Bone mineral density; Children; Cortisol; Fluticasone propionate; Osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; FLUTICASONE PROPIONATE; HYDROCORTISONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

AGE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASTHMA; BONE DENSITY; CALCIUM BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LONG TERM CARE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ANDROSTADIENES; ASTHMA; BONE DENSITY; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; OSTEOCALCIN; PUBERTY; TIME FACTORS;

EID: 84864334733     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000338785     Document Type: Article

References (36)

1. Asher I: The International Study of asthma and Allergies in Childhood (ISAAC). NZ Med J 2008; 121: 117-118.
2. National Asthma Education and Prevention Program: Expert panel report 3: Guidelines for the diagnosis and management of asthma. Full Report 2007. Available online at www.nhlbi.nih.gov./guidelines/asthma/asthgdln.pdf: last accessed September 5, 2007.
3. Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention. Updated 2008. Available online at www.ginasthma.org/guidelineitem.asp. I1=2l2=1intld=60; last accessed February 9, 2009.
4. Derendorf H, Hochhaus G, Meibohm B, Mollman H, Barth J: Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101:S440-S446.
5. Sweetman S (ed): Martindale: The Complete Drug Reference, electronic version. London, Pharmaceutical Press, 2007.
6. Passalacqua G, Albano M, Canonica GW, et al: Inhaled and nasal corticosteroids: safety aspects. Allergy 2000; 55: 16-33. (Pubitemid 30084434)
7. Ebeling PR, Erbas B, Hopper JL, Wark JD, Rubinfeld AR: Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 1998; 13: 1283-1289. (Pubitemid 28373330)
8. Altintas DU, Karakoc GB, Can S, Yilmaz M, Kendirli SG: The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children. Allergol Immunopathol 2005; 33: 204-209. (Pubitemid 41473116)
9. Mainz JG, Sauner D, Malich A, John S, Beyermann H, Mentzel HJ, Kaiser WA, Zintl F: Cross-sectional study on bone density-related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severity. J Bone Miner Metab 2008; 26: 485-492.
10. Roux C, Kolta S, Desfougères JL, Minini P, Bidat E: Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003; 111: 706-713.
11. Allen DB, Bielory L, Derendorf H, Dluhly R, Colice GL, Szefler SJ: Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003; 112:S1-S40. (Pubitemid 37108545)
12. Irwin RS, Richardson ND: Side effects with inhaled corticosteroids: the physician's perception. Chest 2006; 130(suppl 1):41-53.
13. American Thoracic Society: Standardization of spirometry; 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
14. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, et al: Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999; 10: 259-264. (Pubitemid 29476187)
15. Goksen D, Darcan S, Coker M, Kose T: Bone mineral density of healthy Turkish children and adolescents. J Clin Densitom 2006; 9: 84-90. (Pubitemid 44218614)
16. Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, Mahboubi S, Shepherd JA, Hangartner TN, Frederick MM, Winer KK, Kalkwarf HJ: Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010; 95: 1265-1273.
17. Peters PS: Safety of inhaled corticosteroids in the treatment of persistent asthma. J Natl Med Assoc 2006; 98: 851-861.
18. Van Boxtel CJ, Sheffer A (eds.): The pharmacokinetics of fluticasone propionate. Clin Pharmacokinet 2000; 39(suppl):1-54.
19. Barnes NC, Hallett C, Harris TA: Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998; 92: 95-104. (Pubitemid 28112049)
20. Thorsson L, Dahlström K, Edsbäcker S, Källén A, Paulson J, Wirén JE: Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155-161. (Pubitemid 27085366)
21. Pedersen S: Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 2006; 29: 599-612. (Pubitemid 44175030)
22. Hopp RJ, Degan JA, Phelan J, Lappe J, Gallagher GC: Cross-sectional study of bone density in asthmatic children. Pediatr Pulmonol 1995; 20: 189-192.
23. Visser MJ, van der Veer E, Postma DS, Arends LR, de Vries TW, Brand PL, Duiverman EJ: Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Eur Respir J 2004; 24: 420-425. (Pubitemid 39232265)
24. Reilly SM, Hambleton G, Adams JE, Mughal MZ: Bone density in asthmatic children treated with inhaled corticosteroids. Arch Dis Child 2001; 84: 183-187.
25. Akil I, Yuksel H, Urk V, Onur E, Var A, Guvenc Y: Biochemical markers of bone metabolism and renal calcium excretion in the asthmatic patient treated with inhaled corticosteroids (in Turkish). Asthma Allergy Immunol 2004;31: 5-10.
26. Jones CD, Laval-Jeantet AM, Laval-Jeantet MH, Genant HK: Importance of measurement of spongious vertebral bone mineral density in the assessment of osteoporosis. Bone 1987; 8: 201-206.
27. Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, et al: Potential effect of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2004; 79: 458-466. (Pubitemid 38401765)
28. Rizzo MC, Solé D, Naspitz CK: Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy. Allergol Immunopathol (Madr) 2007; 35: 197-208. (Pubitemid 47577375)
29. Barnes NC: Safety of high-dose inhaled corticosteroids. Respir Med 1993; 87: 27-31. (Pubitemid 23099785)
30. Breborowicz A, Niedziela M: Adrenal function in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient condition J Pediatr Endocrinol Metab 2007; 20: 781-789. (Pubitemid 47322705)
31. Sahiner UM, Cetinkaya S, Ozmen S, Arslan Z: Evaluation of adrenocortical function in 3-7 aged asthmatic children treated with moderate doses of fluticasone propionate: reliability of dehydroepiandrosterone sulphate (DHEA-S) as a screening test. Allergol Immunopathol (Madr) 2011; 39: 154-158.
32. Agertoft L, Pedersen S: Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care 1998; 157: 178-183. (Pubitemid 28071280)
33. Johnston CC, Miller JZ, Slemenda CW: Calcium supplementation and increase in bone mineral density in children. N Engl J Med 1992; 327: 82-87.
34. Gagnon L, Boulet LP, Brown J, Desrosiers T: Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma. J Am Diet Assoc 1997; 97: 1401-1406. (Pubitemid 28016319)
35. Alyasin S, Momen T, Kashef S, Alipour A, Amin R: The relationship between serum 25-hydroxy vitamin D levels and asthma in children. Allergy Asthma Immunol Res 2011; 3: 251-255.
36. Ma DQ, Jones G: Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 2002; 38: 497-500. (Pubitemid 35217535)